These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32158439)

  • 61. Fighting tuberculosis by drugs targeting nonreplicating
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens.
    Riccardi N; Del Puente F; Magnè F; Taramasso L; Di Biagio A
    Recent Pat Antiinfect Drug Discov; 2018; 13(1):3-11. PubMed ID: 28625141
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
    Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
    ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z; Zhang Y
    Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone.
    Gopal P; Dick T
    Int J Antimicrob Agents; 2015 Apr; 45(4):430-3. PubMed ID: 25704063
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.
    de Carvalho LP; Lin G; Jiang X; Nathan C
    J Med Chem; 2009 Oct; 52(19):5789-92. PubMed ID: 19736929
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical application of testing methods on acid-fast bacteria].
    Ichiyama S; Suzuki K
    Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease.
    Gordhan BG; Peters J; Kana BD
    Adv Appl Microbiol; 2019; 108():115-161. PubMed ID: 31495404
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains.
    Kumar S; Dwivedi AP; Kashyap VK; Saxena AK; Dwivedi AK; Srivastava R; Sahu DP
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2404-7. PubMed ID: 23474387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M; Rath SN; Sonawane A
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.
    Locher CP; Jones SM; Hanzelka BL; Perola E; Shoen CM; Cynamon MH; Ngwane AH; Wiid IJ; van Helden PD; Betoudji F; Nuermberger EL; Thomson JA
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1455-65. PubMed ID: 25534737
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis.
    Haver HL; Chua A; Ghode P; Lakshminarayana SB; Singhal A; Mathema B; Wintjens R; Bifani P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5316-23. PubMed ID: 26100695
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
    Katalinić-Janković V; Obrovac M
    Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production.
    Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY
    BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel MenA Inhibitors Are Bactericidal against
    Berube BJ; Russell D; Castro L; Choi SR; Narayanasamy P; Parish T
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962346
    [No Abstract]   [Full Text] [Related]  

  • 78. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis.
    Banerjee U; Sankar S; Singh A; Chandra N
    Front Chem; 2020; 8():593497. PubMed ID: 33381491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer.
    Mori G; Pasca MR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.